Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by Cdnguy81on Nov 01, 2018 9:41pm

65 Views

Post# 28911914

RE:RE:RE:TRPX 48 million BO

Bella923 wrote: Market cap has nothing to do with total diluted shares. Look at FSD market cap. There is alot 140 million shares they can issue to bring the 1.3 million to 1.5 million. The market cap will not increase as the share price will adjust for the dilution

Renofund wrote:

Bella923 wrote:
You guys are all getting caught up in the math. Plain and simple, is 48 million dollars that FSD value in company stock. As to the conversion rate? The announcement was based on current outstanding shares of 3.5 million. Is this the actually number? NO. You guys don't think executives and insider with warrants and options will exercise? Of course. This will bring the share count higher. What ever the total share count is on a fully diluted basis of trpx, they will share 48 million. Plain and simple. If total fully diluted share count after exercise irons and warrant is 5 million, then each share is worth 48 million/5 is $9.60. so the final value all depends on the total diluted position of TRPX. Why would executive, make shareholder agree to this deal? Cause they probably have a SH$T load of options and they stand to benefit most as these options are penny on the dollar. Go through trpx Sec filling and you will see the granted options and warrant for the executives. If a deal is to good to be true, they it normal is to good to be true. Why do you think TRPX is not trading near the 13.74 that ppl talk about? Ppl buying TRPX now, Imo is basically buying a separate company and the share price will fluctuate independent of HUGE. If deal falls through, trpx will be back at $4. Who every buying TRPX now is paying a premium. Your upside is capped at the 48 million BO. Your downside could be unlimited if the deal falls thru. However, if HUGE in the next month goes to $2, you can do the math and figure it out and quickly realize buying HUGE at this price point would be the better deal. GLTA

look at TRPX’s current market cap. Thanks.